• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究微芯片流室系统以表征健康个体全血的血栓形成性。

Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.

机构信息

Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.

出版信息

Thromb Res. 2013 Aug;132(2):263-70. doi: 10.1016/j.thromres.2013.05.026. Epub 2013 Jun 16.

DOI:10.1016/j.thromres.2013.05.026
PMID:23777751
Abstract

INTRODUCTION

A whole blood flow-chamber system, the Total Thrombus-formation Analysis System (T-TAS), was developed for quantitative analysis of platelet thrombus formation (PTF) using microchips with thrombogenic surfaces (collagen, PL chip; collagen plus tissue thromboplastin, AR chip) under shear stress conditions. We evaluated the usefulness of the T-TAS for assessing individual thrombogenicity compared with other platelet function tests.

MATERIALS AND METHODS

Blood samples from 31 healthy volunteers were applied to the T-TAS to measure PTF starting time (T10: time to reach 10 kPa), occlusion time (T60 for PL chip; T80 for AR chip), and area under the curve (AUC10, area under curve until 10 min for PL chip; AUC30, 30 min for AR chip) under various shear rates (1000, 1500, 2000s(-1) for PL chip; 300 s(-1) for AR chip). Platelet functions were also tested using platelet aggregometry, the PFA-100 (collagen and epinephrine [C/EPI], collagen and adenosine diphosphate [C/ADP]), and the VerifyNow P2Y12 assay.

RESULTS

Individual pressure waveforms, including PTF starting and ending points, varied among healthy subjects. In the PL chip, T10 and AUC10 showed a shear-dependent correlation with C/EPI or C/ADP. VerifyNow P2Y12 values were not significantly associated with the parameters of the T-TAS. Platelet counts were correlated with all AR measurements, and mostly with PL measurements.

CONCLUSION

The results of the T-TAS were associated with those of the PFA-100 in many respects, indicating that its characteristics are related to shear-induced PTF. The T-TAS showed few correlations with platelet aggregometry and the VerifyNow P2Y12 assay. The T-TAS may allow for the measurement of comprehensive parameters of individual thrombogenicity under whole blood flow conditions.

摘要

简介

我们开发了一种全血流动室系统,即全血栓形成分析系统(T-TAS),用于在切应力条件下使用具有血栓形成表面(胶原、PL 芯片;胶原加组织凝血活酶、AR 芯片)的微芯片定量分析血小板血栓形成(PTF)。我们评估了 T-TAS 用于评估个体血栓形成倾向的有用性,与其他血小板功能测试进行了比较。

材料和方法

将 31 名健康志愿者的血液样本应用于 T-TAS,以在各种切变率(PL 芯片的 1000、1500、2000s(-1);AR 芯片的 300 s(-1))下测量 PTF 起始时间(T10:达到 10 kPa 的时间)、闭塞时间(PL 芯片的 T60;AR 芯片的 T80)和曲线下面积(PL 芯片的 AUC10,直到 10 分钟的曲线下面积;AR 芯片的 AUC30,30 分钟)。还使用血小板聚集仪、PFA-100(胶原和肾上腺素[C/EPI],胶原和二磷酸腺苷[C/ADP])和 VerifyNow P2Y12 测定法测试血小板功能。

结果

个体压力波形,包括 PTF 起始和结束点,在健康受试者中存在差异。在 PL 芯片中,T10 和 AUC10 与 C/EPI 或 C/ADP 呈切变依赖性相关。VerifyNow P2Y12 值与 T-TAS 的参数没有显著相关性。血小板计数与所有 AR 测量值相关,与 PL 测量值大多相关。

结论

T-TAS 的结果在许多方面与 PFA-100 的结果相关,表明其特征与剪切诱导的 PTF 有关。T-TAS 与血小板聚集仪和 VerifyNow P2Y12 测定法的相关性较小。T-TAS 可能允许在全血流动条件下测量个体血栓形成倾向的综合参数。

相似文献

1
Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.研究微芯片流室系统以表征健康个体全血的血栓形成性。
Thromb Res. 2013 Aug;132(2):263-70. doi: 10.1016/j.thromres.2013.05.026. Epub 2013 Jun 16.
2
A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.一种用于定量评估血小板血栓形成过程的微流控芯片室系统。
Microvasc Res. 2012 Mar;83(2):154-61. doi: 10.1016/j.mvr.2011.11.007. Epub 2011 Dec 6.
3
Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.全血栓形成分析系统(T-TAS)可预测接受房颤导管消融术患者的围手术期出血事件。
J Am Heart Assoc. 2016 Jan 25;5(1):e002744. doi: 10.1161/JAHA.115.002744.
4
Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis.评价血栓形成整体分析系统(T-TAS):在人类和小鼠血液分析中的应用。
Platelets. 2019;30(7):893-900. doi: 10.1080/09537104.2018.1535704. Epub 2018 Oct 26.
5
Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.全血栓形成分析系统预测经皮冠状动脉介入治疗的冠心病患者围手术期出血事件。
J Am Heart Assoc. 2017 Apr 24;6(4):e005263. doi: 10.1161/JAHA.116.005263.
6
Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.评估接受抗血小板治疗的冠心病患者的血小板衍生血栓形成性与全血栓形成分析系统。
J Thromb Haemost. 2016 Apr;14(4):850-9. doi: 10.1111/jth.13256. Epub 2016 Feb 19.
7
Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.使用微流控芯片系统评估 1 型血管性血友病患者的临床严重程度。
J Thromb Haemost. 2016 Apr;14(4):667-74. doi: 10.1111/jth.13273. Epub 2016 Mar 15.
8
Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.分析在动脉血流条件下通过测量血小板血栓形成对阿司匹林和氯吡格雷的反应。
Thromb Haemost. 2013 Jan;109(1):102-11. doi: 10.1160/TH12-06-0441. Epub 2012 Nov 22.
9
Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy.测量接受抗血小板治疗的脑血管病患者在动脉剪切条件下的残余血小板血栓形成能力。
J Thromb Haemost. 2016 Sep;14(9):1788-97. doi: 10.1111/jth.13391. Epub 2016 Aug 3.
10
A microchip flow-chamber assay screens congenital primary hemostasis disorders.一种微芯片流动腔检测法可筛查先天性原发性止血障碍。
Pediatr Int. 2021 Feb;63(2):160-167. doi: 10.1111/ped.14378. Epub 2020 Dec 5.

引用本文的文献

1
Total Thrombus-Formation System in Patients with Peripheral Artery Disease.外周动脉疾病患者的血栓形成系统。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241301412. doi: 10.1177/10760296241301412.
2
Ocular Implications of COVID-19 Infection and Vaccine-Related Adverse Events.2019冠状病毒病感染及疫苗相关不良事件的眼部影响
J Pers Med. 2024 Jul 23;14(8):780. doi: 10.3390/jpm14080780.
3
Factors that modulate platelet reactivity as measured by 5 assay platforms in 3429 individuals.在3429名个体中,通过5种检测平台测量的调节血小板反应性的因素。
Res Pract Thromb Haemost. 2024 Apr 12;8(3):102406. doi: 10.1016/j.rpth.2024.102406. eCollection 2024 Mar.
4
T-TAS 01 as a new tool for the evaluation of hemostasis in thrombocytopenic patients after platelet transfusion.T-TAS 01 作为一种新的工具,用于评估血小板输注后血小板减少症患者的止血功能。
Blood Transfus. 2024 Mar;22(2):166-175. doi: 10.2450/BloodTransfus.550. Epub 2023 Nov 29.
5
How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling.新冠病毒结构蛋白引起的免疫反应如何影响视网膜血管内皮细胞:一种免疫血栓形成和/或内皮病变过程的计算机模拟研究。
Immunol Res. 2024 Feb;72(1):50-71. doi: 10.1007/s12026-023-09412-1. Epub 2023 Aug 29.
6
Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients.全血栓形成分析系统作为评估小儿 Fontan 患者血栓形成性和监测抗血栓治疗的工具的效用。
Pediatr Cardiol. 2023 Jun;44(5):1150-1159. doi: 10.1007/s00246-022-03076-8. Epub 2022 Dec 22.
7
Monitoring the coagulation status of trauma patients with viscoelastic devices.使用粘弹性装置监测创伤患者的凝血状态。
J Intensive Care. 2017 Jan 20;5(1):7. doi: 10.1186/s40560-016-0198-4.
8
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System.心血管危险因素与健康个体血栓形成性增加有关:使用全血栓形成分析系统的分析
Thromb J. 2021 Nov 17;19(1):88. doi: 10.1186/s12959-021-00341-3.
9
The Use of Total Thrombus Formation Analysis System as a Tool to Assess Platelet Function in Bleeding and Thrombosis Risk-A Systematic Review.全血栓形成分析系统在出血和血栓形成风险评估中的应用:系统评价。
Int J Mol Sci. 2021 Aug 10;22(16):8605. doi: 10.3390/ijms22168605.
10
Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review.新型冠状病毒感染患者的视网膜表现及发病机制意义:系统综述。
Int Ophthalmol. 2022 Jan;42(1):323-336. doi: 10.1007/s10792-021-01996-7. Epub 2021 Aug 11.